Skip to content

Cancer therapy as a potential trigger for genital polyneuropathy in breast an ovarian cancer patients

Cancer therapy as a potential trigger for genital polyneuropathy in breast an ovarian cancer patients - GenPNP-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030894
Enrollment
1000
Registered
2022-12-19
Start date
2023-01-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyneuropathy of the genitals in breast and ovarian cancer patients.

Interventions

Group 1: Patients with breast or ovarian cancer fill out an anonymous one-time online questionnaire consisting of 51 questions. The aim is to assess the PNP symptoms of the patients in general, but al

Sponsors

Universität zu Köln
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with breast cancer or ovarian cancer. - Patients who are receiving/have received at least 1 of the following cancer therapies: surgery, chemotherapy, radiation therapy, immunotherapy, anti-hormone therapy. - During therapy or in follow-up care - Polyneuropathy of the hands and/or feet

Exclusion criteria

Exclusion criteria: - Age under 18 - No polyneuropathy in hands and/or feet or no temporal correlation to cancer therapy

Design outcomes

Primary

MeasureTime frame
The aim of this study is to find out whether, and if so how often, the symptom of polyneuropathy of the genitals occurs in addition to PNP of the hands/feet in patients after cancer therapy.

Secondary

MeasureTime frame
Improvement in quality of life, improvement and maintenance of sexual activity and satisfaction, possible development of a conservative treatment option.

Countries

Germany

Contacts

Public ContactFreerk Baumann

Universität zu Köln

freerk.baumann@uk-koeln.de+4922147897185

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026